Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Nikki A. Martin"'
Autor:
Florian J. Fintelmann, Nikki A. Martin, Ismail Tahir, Elissa M. Quinn, Timothy C. Allen, Lija Joseph, Boris Nikolic, Christopher Lee
Publikováno v:
Respiratory Research, Vol 24, Iss 1, Pp 1-10 (2023)
Abstract Background Molecular testing can detect actionable genomic alterations and tumor cell surface proteins in patients with non–small cell lung cancer (NSCLC). However, utilization remains suboptimal, representing missed treatment opportunitie
Externí odkaz:
https://doaj.org/article/21d119b2bf3c458ba344978627427f61
Autor:
Jennifer King, Upal Basu Roy, M. Patricia Rivera, Bruce E. Johnson, Adam H. Fox, James R. Jett, Nikki A. Martin, Raymond U. Osarogiagbon, Lauren S. Rosenthal, Gerard A. Silvestri, Robert A. Smith
Publikováno v:
Chest
BACKGROUND: Targeted therapies for advanced non-small cell lung cancer (NSCLC) with oncogenic drivers have caused a paradigm shift in care. Biomarker testing is needed to assess eligibility for these therapies. Pulmonologists often perform bronchosco
Autor:
Nikki A. Martin, Latha Shivakumar, Leigh Boehmer, Ashley Lile, Stephanie A. Cohen, Amy Jo Pixley, Elana Plotkin, Julia R. Trosman, Christine B. Weldon
Publikováno v:
Journal of Clinical Oncology. 40:346-346
346 Background: Biomarker testing is critical in management of aNSCLC, but timely testing for newly diagnosed patients is challenging. Clinician and patient perspectives on barriers to timely biomarker testing for patients with health disparities hav
Publikováno v:
Journal of Clinical Oncology. 40:e18611-e18611
e18611 Background: The benefits of precision medicine, including targeted therapies and immunotherapy, for lung cancer patients are well-documented. National clinical guidelines recommend broad multiplex molecular panels for advanced stage NSCLC. Inc
Autor:
Eric Q. Konnick, Joel E. Tepper, Thomas E. Stinchcombe, Nikki A. Martin, Milind Javle, Veda N. Giri, Heather H. Cheng
Publikováno v:
JCO Precision Oncology
PURPOSEDespite the well-understood benefits of biomarker and genetic testing in precision medicine, uptake remains low, particularly for patients with low socioeconomic status and minority ethnic backgrounds. Patients report having limited familiarit
Autor:
Nikki A. Martin, Janelle Schrag, Cynthia Bens, Claire Saxton, Victor J. Gonzalez, Erica Kuhn, Ronit I. Yarden, Marcia K. Horn, Cassadie Moravek, Gillian W. Hooker, Deborah A. Zajchowski, Christine Verini, Andrea K. Miyahira, Sue Friedman, Reese Garcia, Denisse Montoya, Janine Guglielmino, Beth Davison, Stacie Lindsey
Publikováno v:
Journal of Clinical Oncology. 38:e24164-e24164
e24164 Background: Biomarker testing has advanced precision medicine in cancer. However, not all eligible patients benefit from biomarker-driven therapies due to suboptimal testing rates. A working group of 20 patient advocacy groups representing sol
Autor:
Nikki C. Martin, Robert Gisiner
Publikováno v:
SEG Technical Program Expanded Abstracts 2015.
Autor:
Karen St. John, Nikki C. Martin
Publikováno v:
SEG Technical Program Expanded Abstracts 2014.
In recent years, the potential impacts from anthropogenic sound on marine life, including from geophysical operations, have received increasing attention and scrutiny from government regulators, environmental non-governmental organizations, fishing a
Publikováno v:
Day 3 Wed, March 19, 2014.
Potential impacts from anthropogenic sound on marine life, including from geophysical operations, have received ever-increasing attention in recent years from regulators, environmental non-governmental organizations, fishing organizations and the pub